An open-label, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single doses of GSK2586881 in participants with pulmonary arterial hypertension

  1. Simon, M.A.
  2. Hanrott, K.
  3. Budd, D.C.
  4. Torres, F.
  5. Grünig, E.
  6. Escribano-Subias, P.
  7. Meseguer, M.L.
  8. Halank, M.
  9. Opitz, C.
  10. Hall, D.A.
  11. Hewens, D.
  12. Powley, W.M.
  13. Siederer, S.
  14. Bayliffe, A.
  15. Lazaar, A.L.
  16. Cahn, A.
  17. Rosenkranz, S.
Revista:
Pulmonary Circulation

ISSN: 2045-8940,  2045-8932

Any de publicació: 2022

Volum: 12

Número: 1

Tipus: Article

DOI: 10.1002/PUL2.12024 GOOGLE SCHOLAR lock_openAccés obert editor
Font de les dades: Scopus